The Southern Hemisphere’s first cell-based vaccine manufacturing facility has opened in Tullamarine. The new CSL Seqirus facility will be able to supply Australia with critical health products, including pandemic and seasonal influenza vaccines, lifesaving antivenoms and Q-Fever vaccines. The $1 billion, ten-year agreement between the…
Digital Editions
-

AI brings Wollert history to life
A new exhibition at a Wollert retirement village uses artificial intelligence (AI) to bring the region’s history to life. A Journey Through Time – The…
















